Rheumatoid arthritis is a chronic autoimmune disorder causing inflammation of synovial joints, leading to pain, stiffness, ...
Tocilizumab, a biologic disease-modifying antirheumatic drug targeting interleukin 6, reduces disease activity more ...
Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...
A significant number of people with rheumatoid arthritis (RA) experience financial distress, particularly if they also suffer ...
The current obsession with inflammation may seem new, but at the University of Arizona’s Andrew Weil Medical Center for ...
Garba, H. , Bouchrane, R. , Bah, A. , Aziz, H. , Niasse, M. and Saïdou, D. (2025) Spinal Disorders in Sub-Saharan Africa: A 10-Year Hospital Experience from Senegal. Open Journal of Rheumatology and ...
Sleep disorders are common in patients with rheumatoid arthritis, and many of them are significantly tied to greater clinical ...
The provisional patent application, titled, “Raphael Pharmaceutical, Inc. / Rambam MedTech Formula for Treating Neutrophil-Dominant Autoimmune Diseases (including RA)” (No. 63/911,729), was filed ...
Hip and knee pain often stems from arthritis, a condition affecting joints. Understanding its causes, like aging or ...
Patients with EDs are linked to an increased risk of developing RA, with associations more pronounced among men vs women.
Statin therapy may attenuate the elevated MACE risk typically observed with tofacitinib vs TNF inhibitors among patients with RA and pre-existing ASCVD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback